IL10 and pulmonary fibrosis: For example, in asthma, let-7 may exacerbate Th2-driven inflammation by targeting IL-10, whereas in pulmonary fibrosis, let-7d inhibits epithelial-to-mesenchymal transition and may act protectively [13,16,24].